AFGV.F Stock Overview
Agfa-Gevaert NV develops, produces, and distributes various analog and digital imaging systems worldwide.
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 3/6 |
Past Performance | 0/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
Agfa-Gevaert NV Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €1.21 |
52 Week High | €2.57 |
52 Week Low | €1.21 |
Beta | 0.63 |
1 Month Change | 0% |
3 Month Change | n/a |
1 Year Change | n/a |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -94.24% |
Recent News & Updates
Recent updates
Shareholder Returns
AFGV.F | US Healthcare Services | US Market | |
---|---|---|---|
7D | 0% | -0.8% | 1.0% |
1Y | n/a | -9.6% | 21.9% |
Return vs Industry: Insufficient data to determine how AFGV.F performed against the US Healthcare Services industry.
Return vs Market: Insufficient data to determine how AFGV.F performed against the US Market.
Price Volatility
AFGV.F volatility | |
---|---|
AFGV.F Average Weekly Movement | n/a |
Healthcare Services Industry Average Movement | 9.7% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.8% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: AFGV.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine AFGV.F's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1867 | 7,000 | Pascal Juery | www.agfa.com |
Agfa-Gevaert NV develops, produces, and distributes various analog and digital imaging systems worldwide. It operates through four segments: HealthCare IT, Digital Print & Chemicals, Radiology Solutions, and CONOPS. The company’s CONOPS segment engages in supply of film and chemicals, as well support services.
Agfa-Gevaert NV Fundamentals Summary
AFGV.F fundamental statistics | |
---|---|
Market cap | US$192.99m |
Earnings (TTM) | -US$56.76m |
Revenue (TTM) | US$1.23b |
0.2x
P/S Ratio-3.4x
P/E RatioIs AFGV.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
AFGV.F income statement (TTM) | |
---|---|
Revenue | €1.15b |
Cost of Revenue | €792.00m |
Gross Profit | €358.00m |
Other Expenses | €411.00m |
Earnings | -€53.00m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 14, 2024
Earnings per share (EPS) | -0.34 |
Gross Margin | 31.13% |
Net Profit Margin | -4.61% |
Debt/Equity Ratio | 3.5% |
How did AFGV.F perform over the long term?
See historical performance and comparison